In biology, the production of reactive oxygen species (ROS) is a physiological and regulated process, but an uncontrolled increase can become pathological, lead to oxidative stress (OS), and trigger various diseases, as a consequence of an imbalance between radical production and endogenous antioxidant defense systems, which may be unable to mitigate their production. Over the last few years, there has been an abundance of research on the generation and effects of ROS on biological processes, mainly on proteins, lipids, and cellular DNA [1].

Polyphenolic compounds are characterized by having at least one benzene ring with two or more hydroxyl (OH) groups [2]. There are more than 8000 polyphenolic compounds in nature, classified into flavonoids, phenolic acids, lignans, and stilbenes [3]. The elemental structure of flavonoids, called aglycone, has two benzene rings linked by a three-carbon bridge, with a C6-C3-C6 skeleton [3].

Numerous studies have demonstrated the health benefits of dietary polyphenols, but some confusion remains as to their mechanistic action in vivo [4]. Currently, phenolic compounds are incorporated into foods because of their multiple functions, including their antioxidant and anti-inflammatory capacity, and they possess antimicrobial properties [5]. Stilbenes, phenolic acids, anthocyanins, flavanols, and isoflavones are all examples of polyphenols with anti-infective potential, as they can induce and/or modulate the synthesis of host defense peptides (HDPs) in various animal species. However, further research is needed to fully understand the complex interactions between polyphenols and HDPs [6]. Some of the properties of polyphenols are summarized in Figure 1.

In recent decades, polyphenols have received enormous attention from scientists and nutritionists for their role in human health, as they can help prevent or even treat diseases such as cancer, cardiovascular disease (CVD), and neurological disorders [7]. Their therapeutic effects are based on the antioxidant capacity as free radical scavengers and their involvement in the regulation of cell signaling pathways and gene regulation and expression [8].

Its well-known antioxidant effect is based on its ability to donate a proton H⁺ to free radicals, such as hydroxyl, peroxyl, etc., which in turn lose their reactivity, forming a relatively stable flavonoid radical, called a phenoxyl radical [9]. This proton is derived from the OH group present in the aromatic rings of polyphenols. This mechanism is explained in some detail for three polyphenols have been selected: resveratrol, hydroxytyrosol, and luteolin. Figure 2 characterizes the main mechanisms of antioxidant action.

Polyphenols also act as chelators of metals such as Fe, reducing the kinetics in the Fenton reaction [10]. They are also involved in the inhibition of oxidant enzymes, such as lipoxygenase (LO) [11], cyclooxygenase (COX) [12], myeloperoxidase (MPO) [13], NADPH oxidase (NOx) [14], and xanthine oxidase (XO) [15], thus preventing the generation of reactive oxygen species (ROS) [16], and stimulate others with antioxidant properties, such as catalase (CAT) [17] and superoxide dismutase (SOD) [18].

It is worth mentioning the importance of the efforts being made in the development of new synthetic antioxidants. One such effort is the work of Rabecca Jenifer et al. on the rational design of heterocyclic molecules incorporated into sugar-triazole derivatives for antioxidant studies [19].

To carry out this study, three polyphenols have been selected which are usually present in the human diet and which are widely known, that is, resveratrol, hydroxytyrosol, and luteolin. Their molecular structure is expressed in Table 1:

Resveratrol is a stilbenoid that occurs naturally in various plants in response to injury or attack by pathogens such as fungi or bacteria [20]. Some studies have indicated that resveratrol activates sirtuin SIRT1 and improves mitochondria function [21]. In cells treated with resveratrol, it is observed that the action of superoxide dismutase depends on manganese MnSOD (SOD2), which increases up to 14 times [22]. There are also numerous studies associating beneficial effects of resveratrol in cancer and in cardio- and neuro-protective effects [23].

Hydroxytyrosol is a derivative of catechol found in a variety of natural sources, particularly olive oil and wine. Olives, leaves, and olive pulp contain large amounts of oleuropein, the most common hydroxytyrosol derivative [24]. HT is a new safe food for human consumption, with a level of unobserved adverse effects of 50 mg/kg of body weight per day, as evaluated by the European Food Safety Authority (EFSA) [25]. The Mediterranean diet is characterized by the regular intake of olive oil, which positively affects human health, including a reduction in cardiovascular disease rates ^[26][27][26,27]. Consuming olive oil, hydroxytyrosol, and oleuropein may inhibit the oxidation of LDL cholesterol, a risk factor for atherosclerosis, heart attack, or stroke [28].

Luteolin (3′,4′,5,7-tetrahydroxyflavone) is a flavone present, in its glycosylated form, in different fruits and vegetables, and numerous studies have indicated that it has antioxidant, anticarcinogenic, anti-inflammatory, and neuroprotective effects [29]. Luteolin inhibited lipopolysaccharide LPS-induced release of TNF-α, IL-6, and NO by macrophages and significantly decreased the secretion of INF-γ, IL-6, COX-2, and iNOS in alveolar macrophage and peripheral macrophage cell lines [30]. This anti-inflammatory action was accompanied by suppression of the transcription factor NF-kβ (nuclear factor enhancer of kappa light chains of activated β cells; its defective regulation is associated with cancer, inflammatory and autoimmune diseases, septic shock, viral infections or inadequate immune development). Luteolin also suppresses inflammation in brain tissues and regulates different cell signaling pathways in neurodegenerative diseases and neuronal cell death [31].

The characteristic antioxidant potential of these three compounds is based on the phenolic OH group, which can donate H⁺ and remove the unpaired electron through the resonant electron system [32]. The OH groups donate a proton to various radicals ^•X such as hydroxyl, peroxyl, superoxide, or peroxynitrous acid, which lose their reactivity and in turn form a relatively stable flavonoid radical, called the phenoxyl radical [33]. Figure 3, Figure 4 and Figure 5 show the preferred positions for the formation of phenoxyl radicals for resveratrol, hydroxytyrosol, and luteolin, respectively. Figure 6, Figure 7 and Figure 8 show the resonant structures after formation of the phenoxyl radical in the different positions that are advantageous.

For hydroxytyrosol, the odd electron is delocalized by the two benzene nuclei through the C=C double bond.

In hydroxytyrosol, the odd electron is only delocalized by the benzene nucleus, whether the radical is generated at the OH of C-3 or C-4.

The interaction of a FR (^•X) at the OH of the C-7 position resulted in the electron delocalization throughout the A-ring (Figure 7). When ^•X is generated at C-7 and C-4′ OH positions of luteolin, there is a greater delocalization of the unpaired electron, yielding a greater number of resonant forms (in blue and red). OH located at 7 and 4′ positions were predicted to have greater antioxidant activity.

In luteolin, the radical formed at both C-7 and C-4′ is resonance-stabilized due to conjugation with the ketone or with the double bond and the ketone, respectively.

For the selected compounds, in the aromatic groups, the presence of a phenolic group (at the B-ring of resveratrol), catechol (at the aromatic ring of hydroxytyrosol and at the B-ring of luteolin), and resorcinol (at the A-rings of resveratrol and luteolin) have been observed (Figure 9).

Resorcinol shares many characteristics with phenol and deprotonates [34]. Catechols (less acidic than resorcinol) are part of many essential chemicals and are valuable, typically nucleophilic intermediates used in synthesis [35].

Phenols and polyphenols are nucleophiles susceptible to electrophilic substitution reactions due to their high electron density [36]. The phenolic OH group facilitates the effective delocalization of the charge in the aromatic ring through resonance. In electrophilic aromatic substitution reactions, an electrophile substitutes one or more hydrogen atoms attached to the aromatic ring ^[37][38][37,38] (Figure 10).

In contrast, due to the aromatic ring system, quinones are resonance-stabilized electrophiles [39] (Figure 11).

Polyphenols are oxidized by several oxidative enzymes, including cytochrome P450, COX-2, peroxidase, tyrosinase, XO, monoamine oxidase (MAO), and polyphenol oxidases (PPO)into highly reactive quinones [40]. PPO (widely distributed in the animal and plant world) is a group of copper-containing enzymes that catalyze the o-hydroxylation of monophenols to catechols and the oxidation of catechols to quinones in the presence of oxygen [41]. The hydroxylation reaction is kinetically slower than the oxidation reaction. As a result, quinones are obtained as products [42] (Figure 12).

The most important structural feature of PPO is the presence in its active center of two copper atoms, bound to histidines; around the coppers, hydrophobic amino acids are located. The active sites have a trigonal pyramidal structure coordinated by the spheres formed by the three histidine ligands and the solvent molecule as a bridge. The reaction mechanism of PPO, shown in Figure 13, is a two-step catalysis.First is the oxidation of a monophenol to o-diphenol and the subsequent oxidation of this to o-quinone, i.e., a consecutive cresolase and catecholase activity. The enzyme first binds oxygen and then monophenol. A valence change of the copper ions from Cu¹⁺ to Cu²⁺ occurs, forming a complex with an O-O bond where the diphenol is generated. The o-diphenol is then oxidized to o-quinone, which completes the cycle [43].

In polyphenols, the oxidation of a catechol configuration leads to the formation of an o-quinone structure, which can react with the sulfhydryl group of cysteine in glutathione or with the cysteine residues ofproteins [46]. This modification may be important for understanding the redox regulation of cellular functions that can be induced during polyphenol oxidation. Quinones formed by these reactions are active and covalently bond to nucleophilic side chains [47].

In the oxidation process of polyphenols to quinones, ROS are generated as part of the O₂-reducing process, so this route is considered genotoxic [48]. Additionally, quinones are able to create DNA adducts, which cause genetic mutations [49]. ROS produce DNA strand breaks and oxidatively damaged nucleobases [50]. The genotoxicity of o-quinones is aggravated by the nuclear translocation of estrogen o-quinones by the estrogen receptor and by the nuclear translocation of polycyclic aromatic o-quinones by the aryl hydrocarbon receptor [51].

PPO is involved in the oxidation of phenolic compounds in fruits and vegetables, and this action is significant, as it reduces food quality, because oxidation induces the production of dark compounds (browning), which leads to consumer rejection and decreases the antioxidant capacity of foods [52]. The browning is generally assumed to be a direct consequence of phenolic compound oxidation by PPO action. Quinone formation can undergo polymerization processes and cause yellow and brown coloration [53].

In summary, polyphenolic compounds oxidize quite easily, despite the fact that in their FR-scavenging process, they donate a proton from the OH phenolic group and that the phenoxyl radical formed is relatively stable. The redox equilibrium between catechol and dihydroquinone and their oxidation to quinones readily drive those compounds to the oxidized state. During this process, the phenoxyl radical progressively donates reducing species, that is, H⁺ and e⁻,which are used to reduce the O₂ or ^•O₂⁻ to H₂O₂ [54]. Thus, they behave analogously to the complexes present in the mitochondrial electron transport chain (ETC), but do not obtain H₂O as an end product, as occurs in the ETC, but rather H₂O₂ and, ultimately, the hydroxyl radical (^•OH).

The oxidation reactions of the three selected compounds, resveratrol, hydroxytyrosol, and luteolin will provide the corresponding o-quinones [48] (Figure 14):

Enzymatic oxidation of the B-ring of resveratrol proceeds according to a two-step process, in the first of which cytochrome P450 oxidizes phenol to catechol and subsequently PPO oxidizes catechol to o-quinone [55] (Figure 15).

Quinones are potent redox compounds that are readily reduced by electron-catalyzed P450/NADPH oxidoreductase 1 (NQO1), generating semiquinone radical anions [56]. The intermediate semiquinone radicals are very unstable and are easily oxidized to quinones by molecularO₂. The reduction of molecular O₂ generates ^•O₂⁻, which is dismutated by superoxide dismutase(SOD)to H₂O₂, which in turn is reduced by the Fenton reaction to ^•OH and OH⁻, the highly reactive hydroxyl radical [57]. This redox cycling is responsible for OS within cells and is a major contributor to overall quinone [58]. Most quinones can also be reduced back (by 2e⁻) to the hydroquinone or catechol, a reduction process catalyzed by NQO1, which represents a major detoxification mechanism [57]. The redox balance between the p-quinone/hydroquinone and o-quinone/catechol pairshas an important effect on its pro-oxidant/antioxidant effects and on its cytotoxic/cytoprotective biological properties [59].

Quinones (as electrophilic compounds), are susceptible to reacting with glutathione (GSH) and usually this reaction is so simple that enzymatic catalysis by glutathione S-transferase (GST) is not necessary [60]. GSH can also be oxidized to GSSG by hydroxyl radicals generated during the quinone redox cycle [61].

Quinones are formed in the 2H⁺/2e⁻ process of oxidation of catechol (1,2-dihydroxybenzene) and hydroquinone (1,4-dihydroxybenzene) [62]. However, the oxidation of resorcinol is significantly different from that of catechol and hydroquinone, including the reversibility of the process and the characteristics of the physicochemical responses [63]. The oxidation of resorcinol is a complicated process, and although theoretically its oxidation is an irreversible process forming 4-cyclohexene-1,3-dione and one would expect a similar reaction to the oxidation of catechol and hydroquinone, in practice, quinone formation is not the only possible route for the oxidation of resorcinol [64]. The oxidation pathway for resorcinol involves the formation of radical intermediates, which form dimer/polymer products [65].

An antioxidant is a substance that inhibits or prevents oxidation, a chemical reaction of electron transfer from a substance to an oxidizing agent [66]. A pro-oxidant is any compound that accelerates oxidation or induces ROS, which can result in damage to cellular components and contribute to the development of various diseases [67]. Pro-oxidants interfere with the action of the body’s antioxidant enzymes and pathways, reducing their effectiveness in scavenging ROS and protection against oxidative damage [68]. There is a body of scientific literature that supports the idea that polyphenols are generally antioxidants that can act as pro-oxidants under certain conditions [69]. This concept is not correct and can lead to misunderstandings.

Some of the mechanisms of the antioxidant activity of polyphenolic compounds are listed below (Figure 16).

Antioxidant capacity can be summarized in the following items:

• They can prevent the initiation of the chain of oxidation reactions by combining with initiator radicals, such as hydroxyl radicals, e.g., caffeic acid or hydroxytyrosol [70].
• They can decompose peroxides by converting them to non-radical species [71].
• They can act as free radical scavengers [72].
• They can act as chelating agents for transition metal ions and reduce the possibility of generating free radicals (as in the Fenton reaction) [73].
• They can bind to cell membranes or combine with other biomolecules, thus reducing the consumption of metabolic antioxidants [74].
• Polyphenolic compounds have the ability to induce, activate, inhibit, or protect enzymatic metabolism [75].
• The antioxidant activity of polyphenols is well-known and derives from a combination of their Fe-chelating and FR-scavenging properties, together with their inhibitory activity on oxidase enzymes, lipoxygenase (LO), cyclooxygenase (COX), myeloperoxidase (MPO), NADPH oxidase (NOX), and xanthine oxidase (XO), thus preventing the endogenous generation of ROS in vivo [76].

The best-known antioxidant role of polyphenolic compounds is the scavenging of free radicals in lipid oxidation protection processes by reacting with the peroxyl radical [77]. The nature of the chemical structure of the polyphenolic compound has a major influence on its antioxidant activity. Polyphenolic antioxidants are excellent hydrogen and electron donors to hydroxyl, peroxyl, and peroxynitrite radicals and their radical intermediates are stable, due to the resonance delocalization of the unpaired electron within the aromatic ring and the absence of reactive positions towards O₂ [78].

In summary, the structure of polyphenols, the number of OH groups, and substitution patterns on the benzene ring affect the antioxidant activity of polyphenols.

Pro-oxidant effects of polyphenols include transient reduction of Cu²⁺ to Cu⁺, formation of ROS, and potential disruption of cellular antioxidant defense, such as glutathione and glutathione-S-transferase [79].

The mechanisms underlying this effect are the formation of a labile aroxyl or a labile flavonoid-redox complex [80]. These mechanisms can produce H₂O₂, which can lead to Hb oxidation [81], and release Fe⁺² ions to undergo auto-oxidation or even engage in a redox process, thus acting as pro-oxidants, which explains the mutagenic and genotoxic properties [82].

The pro-oxidant activity of flavonoids includes their oxidation to o- or p-quinones [83], which are highly reactive towards nucleophilic thiols and amino groups of proteins and glutathione. The B-ring structure of flavonoids (usually a catechol or a simple phenol) is readily oxidized and leads to the formation of electrophilic o-quinones, whereas resorcinol (more common in the A-ring of flavonoids) is not oxidized [84].

The definition of a pro-oxidant substance also includes substances that cause ROS or oxidative damage [85], as is the case here, which includes all reactive molecules containing FR in cells or tissues.

There has always been a great scientific curiosity about the mechanism of action of polyphenols, their antioxidant capacity, and the relationship with the endogenous antioxidant defense [16]. At this time, although many mechanisms remain to be discovered (especially those related to its anti-inflammatory capacity), enough is already known about its antioxidant action and its influence on the prevention of different diseases. For example, in Spain, the study PREDIMED (Prevention with Mediterranean Diet) was conducted between 2003 and 2011 and included 7447 participants aged 55–80 years (58% women) at high cardiovascular risk, but initially free of the disease. It was shown that the groups treated with the Mediterranean diet achieved a statistically significant reduction in the rate of the main cardiovascular risk (myocardial infarction, stroke, or cardiovascular death) [86].

Polyphenols undergo extensive metabolism in the gastrointestinal tract (GIT) lumen, enterocyte (GIT epithelial cells responsible for the absorption of various essential nutrients), and liver [87]. Their absorption is reduced and slow [88], which contradicts the notion that their antioxidant activity may play an important role, as attributed to them.

Joseph Kanner, 2020, maintains that polyphenols generate H₂O₂ in the blood system, in the exogenous zone of the endothelial cell membrane. H₂O₂ enters the cells through aquaporin, the protein channels generally associated with water transport. The H₂O₂ concentration is around 0.1–2 µM and penetrates the cells between 0.01 and 0.1 µM to improve the adaptation and survival of the organism [89].

To determine antioxidant activity, methods are based on testing how an oxidizing agent induces oxidative damage to an oxidable substrate, which is inhibited or reduced in the presence of an antioxidant ^[90][91]. This inhibition is proportional to the antioxidant activity of the compound. Other assays are based on the quantification of the products formed after the oxidative process ^[91][92].

Antioxidant capacity is studied by several widely known methodologies, such as the 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid (ABTS), the 2,2-diphenyl-1-picrylhydrazyl (DPPH), the N,N-dimethyl-ρ-phenylenediamine (DMPD), the Oxygen Radical Absorbance Capacity (ORAC), and the Ferric-Reducing Antioxidant Power (FRAP) assay. In the presence of antioxidants, the ferric form of the compound iron-tripyridyl-triazine (Fe³⁺-TPTZ) is reduced to the ferrous form (Fe²⁺-TPTZ). The Fe²⁺-TPTZ compound produces an intense blue coloring with an absorption maximum of 593 nm ^[92][93]. The FRAP method does not evaluate the free radical-scavenging capacity of the sample under study, but its reducing capacity by electron transfer and the ABTS and DPPH methods evaluate the capacity of the sample to neutralize free radicals ^[93][94]. The DPPH method studies the reduction of the 2,2-diphenyl-1-picrylhydrazyl radical upon reaction with H+ donor substances ^[94][95]. The generation of the DPPH radical is fast and without prior preparations, while that of the ABTS radical requires the use of chemical (manganese dioxide, potassium persulphate), enzymatic (peroxidase, myoglobulin), or electrochemical agents ^[92][93].

There are other techniques that measure antioxidant capacity, such as CUPRAC (cupric ion-reducing antioxidant capacity), ABAP (2′-azobis(2-amidopropane) depletion), DMPO (N-5,5-dimethyl-1-pyrroline oxide depletion), ORAC (oxygen radical absorbance capacity), and TRAP (total antioxidant capacity), among others ^[95][96].

Quinones are toxicological intermediates with a variety of hazardous effects in vivo, such as cytotoxicity, immunotoxicity, and carcinogenesis, but they can also be cytoprotective through the induction of antioxidant, detoxifying, and anti-inflammatory genes by modifying the cellular redox state [58].

Keap1 is the Kelch-like ECH-associated protein 1, NRF2 is the Nuclear factor erythroid 2-related factor 2, and ARE is the Antioxidant Response Elements ^[96][97]. In biology, the NRF2-ARE axis is a complex that regulates cellular antioxidant responses against oxidative stress, as well as cell proliferation ^[97][98]. Under normal conditions, the NRF2 factor is targeted by Keap1, which promotes its proteasomal degradation. Keap1 functions as a sensor of stress signals, through induced oxidation at key cysteine residues ^[98][99]. These conformational changes promote the release of NRF2 by the NRF2/Keap1 complex and once NRF2 release occurs, it translocates to the nucleus. Here, NRF2 induces phase II cytoprotective genes ^[99][100].

Phase II metabolic enzymes are a battery of critical proteins that detoxify xenobiotics (xenobiotics are chemicals extrinsic to physiological metabolism and to which an organism is exposed by ingestion, inhalation, or through the skin), with protective and preventive effects due to the induced regulation via the Keap1/NRF2/ARE pathway ^[100][101]. Phase II enzymes expressed by ARE include UDP-glucuronosyl transferases, sulfotransferases, N-acetyl transferases, glutathione S-transferases, and methyltransferases (mainly thiopurine S-methyl transferase and catechol O-methyl transferase). Impaired phase II enzyme activity can also lead to toxic effects of unmetabolized drugs ^[101][102].

Some specific enzymes produced by ARE genes are ferritin, heme oxygenase 1 (HO-1), NAD(P)H quinone oxidoreductase (NQO1), thioredoxin reductase (TrxR), and glutathione-metabolizing genes (glutathione peroxidase (GPx), glutathione s-transferase (GST), γ-glutamyl transpeptidase (GGT), glutathione-disulfide reductase (GSR), and glutamyl cysteine ligase (GCL)) ^[102][103].

NAD(P)H quinone oxidoreductase 1 (NQO1) catalyzes the 2e⁻ reduction of quinones to hydroquinones, catechols, and a broad range of organic compounds ^[103][104]. Its physiological function is to reduce the free radical load in cells and the detoxification of xenobiotics ^[104][105][105,106].

Polyphenols possess a nucleophilic catechol moiety and their oxidized form (as o-quinone), formed after 2H⁺ and 2e⁻ donation, induces the NRF2 factor due to the influence of its electrophilic character ^[106][107]. Indeed, when the Keap1 protein senses electrophilic stress, NRF2 is released from Keap1-mediated repression and accumulates in the nucleus, strongly inducing the expression of the cytoprotective gene set ^[107][108].

Keap1 is an intracellular protein sensor endowed with 27 reactive cysteine residues that act as receptors for electrophiles and oxidizing agents such as ROS ^[108][109], and 10 of these cysteines are adjacent to positively charged amino acids (maintaining the cysteine sulfhydryl group in a reactive state). The Keap1 protein acts as a sensor endowed with 27 reactive cysteine residues that function as receptors for electrophilic compounds and ROS agents ^[108][109]. Under OS, the cysteine residues of Keap1 are modified, causing a conformational change that prevents NRF2 ubiquitination ^[107][108]. The IVR domain of Keap1 contains reactive cysteine residues key to regulating NRF2 activity, including Cys226, Cys257, Cys273, and Cys288. So, NRF2 dissociation from Keap1 is mediated by oxidative modification of specific cysteine residues ^[109][110]. Cys273 and Cys288 are required for OS detection under both basal and stress conditions, whereas Cys151 (in the BTB domain of Keap1, surrounded by a cluster of positively charged amino acids) may be required only during OS conditions ^[110][111]. Cys226, Cys613, Cys622, and Cys624 specifically detect H₂O₂ through a mechanism different than that used to detect other electrophilic NRF2 inducers ^[111][112]. Tests on NRF2-null mice have revealed the contribution of NRF2 to genetic protection against various diseases caused by electrophilic and oxidative stress ^[112][113].

The thiol group of cysteine (Cys-SH) has a high reactivity with ^•O₂⁻ and H₂O₂ species ^[113][114], NO-derived species ^[114][115], and electrophilic byproducts of redox reactions ^[115][116], modifying the thiol group to sulfide derivatives (sulfenic (Cys-SO⁻), sulfinic acid (Cys-SO₂⁻), sulfonic acid (Cys-SO₃²⁻), S-nitrosothiol (Cys-S-NO), and disulfides) ^[115][116]. Most of the sulfide derivatives come from the oxidation of the thiol group of cysteine, for example, by the effect of quinones, acting as oxidants ^[116][117].

Cysteine is the most nucleophilic amino acid of proteins and readily undergoes Michael addition with electrophiles ^[117][118]. A donation and acceptance of electrons takes place between a nucleophile and an electrophile ^[118][119]. A nucleophile contains an excess of electrons in the form of a negative charge (as the phenoxyl radical of polyphenols) and an electrophile may be inherently electron-deficient. The thiol group of the cysteine reacts by donating a pair of electrons to the electrophile, resulting in the formation of a covalent bond ^[119][120].

Quinones are Michael acceptors and readily react with nucleophiles like the sulfhydryl group on cysteine ^[120][121]. O-quinones generally undergo 1,6-reductive addition reactions with thiol nucleophiles, although 1,4-reductive addition is often observed as a minor product ^[121][122] (Figure 17).

The transcription factor BTB and CNC homology 1 (Bach1) is widely expressed in most mammalian tissues and its function is to act as a transcriptional suppressor ^[122][123]. Bach1 plays a key regulatory role in ROS production, cell cycle, heme homeostasis, hematopoiesis, and immunity, suppresses ischemic angiogenesis, and promotes breast cancer metastasis ^[123][124]. Bach1 inhibits the transcription of many OS response genes, including HO-1 and NQO1 ^[124][125]. Bach1, like Keap1, is a negative regulator of NRF2 that controls the ARE-dependent gene expressions ^[125][126]. Chuanyang Su et al. found that the electrophilic character of quinones is essential for the suppression of Bach1. Fe³⁺ enhanced NRF2 activation and ARE-driven gene expressions, suggesting quinones rather than catechol activate NRF2 through Bach1 arylation. The electrophilic character of quinones ensures their conjugation with Bach1 ^[126][127]. The Fenton reaction occurs in the presence of Fe²⁺ and H₂O₂, yielding Fe³⁺ and ^•OH + OH⁻ (Figure 18).

Alternatively, the activation of NRF2 also occurs by H₂O₂ release, which is generated during the oxidation of polyphenols in aqueous media in the presence of oxygen or ^•O₂^{− [127]}[128]. Polyphenols, in the oral human cavity, generate considerable levels of H₂O₂, involving interactions with transition metal ions ^[128][129]. Oxidation of polyphenols produces^•O₂⁻, H₂O₂, and a complex mixture of semiquinones and quinones ^[128][129].

Polyphenols are capable of modulating numerous processes, both at the level of transcription factors and cellular enzyme metabolism. Polyphenols are inhibitors of a variety of enzymes, including oxidative enzymes (such as XO and lipoxygenase), protease enzymes (which are involved in the breakdown of proteins), and inflammatory enzymes (such as COX-2) ^[129][130].

Dietary polyphenols also possess potential inhibitory activity against α-amylase (hydrolyzes α-1,4-glycosidic bonds of α-linked polysaccharides) and α-glucosidase (catalyzes the hydrolysis of non-reducing α-1,4 glucose molecules of disaccharides or oligosaccharides), the enzymes that convert the starch present in food into glucose. Hyperglycemia is one of the most common nutritional disorders in the world today ^[130][131]. Starch is a polysaccharide found in cereals, tubers, legumes, and some fruits and vegetables. It is the main source of energy in the human diet and the inhibition of the two enzymes described above contributes to the control of diabetes ^[131][132].

NF-κB is a family of five transcription factors involved in various physiological and pathological processes, such as immune function, apoptosis, carcinogenesis, and inflammatory diseases ^[132][133]. In cancer cells, NF-κB provides the ability to survive by upregulating anti-apoptotic genes, such as those in the BCL-2 family ^[133][134], and enhances drug resistance through the expression of resistance genes, such as resistance gene 1 (mdr1) ^[134][135].

Dysregulation of NF-κB signaling is implicated in several chronic diseases, such as inflammatory disorders, autoimmune diseases, and cancers ^[135][136]. Numerous studies have investigated the ability of polyphenols to modulate NF-κB signaling and have shown that they exert inhibitory effects on NF-κB activation through a variety of mechanisms ^[136][137]. (i) Polyphenols can inhibit the activity of IKK, the enzyme that phosphorylates IκB proteins. Polyphenols can block IKK activity and thus prevent translocation of NF-κB to the nucleus ^[137][138]. (ii) They indirectly inhibit NF-κB activation, due to its antioxidant properties ^[138][139]. (iii) They influence the composition of NF-κB subunits, altering the activity of the NF-κB complex (as the p65 subunit, a key component of the NF-κB complex) ^[139][140]. (iv) They disrupt upstream signaling pathways of NF-κB activation, such as receptors like Toll-like receptors (TLRs) or cytokine receptors, thereby inhibiting the initiation of NF-κB signaling cascades ^[140][141]. (v) They can modify epigenetic markers, such as DNA methylation ^[141][142] and histone modifications ^[142][143], altering the accessibility of NF-κB target genes. Examples of polyphenols that have been studied for their NF-κB-inhibitory effects include curcumin ^[143][144], resveratrol ^[144][145], quercetin ^[145][146], and epigallocatechin gallate (EGCG) ^[146][147].

AP-1 is a dimeric transcription factor, composed of proteins from the c-Fos, c-Jun, ATF, and JDP families, that is involved in the regulation of a wide range of cellular processes, including cell growth, differentiation, and apoptosis ^[147][148]. It is activated by a variety of stimuli, including OS, viral or bacterial infections, inflammation, and DNA damage ^[148][149]. AP-1 activation involves the following steps:

• Phosphorylation of the transcription factors c-Jun and c-Fos, initially inactive, as they are bound to a protein called c-Jun-associated protein (JUN-AP). Phosphorylation of c-Jun and c-Fos by protein kinases separates them from JUN-AP and allows them to dimerize.
• Once phosphorylated, c-Jun and c-Fos can dimerize to form the active AP-1 complex, which can then bind to specific DNA sequences, called AP-1 binding sites, activating the transcription of genes involved in differentiation, proliferation, and apoptosis.

Growth factors activate AP-1 through the MAP kinase pathway ^[149][150], whereas cytokines activate AP-1 through the NF-κB pathway ^[150][151]. OS can activate AP-1 through a variety of signaling pathways, including the cAMP-dependent protein kinase (PKA) pathway, the JNK pathway, and the p38 MAPK pathway, which ultimately lead to the phosphorylation and activation of c-Jun and c-Fos ^[151][152]. DNA damage can activate AP-1 through the p53 pathway, activating a series of genes that are involved in DNA repair and cell death, as c-Jun ^[152][153]. The activation of AP-1 is a tightly regulated process that is essential for many cellular processes ^[153][154]. However, the dysregulation of AP-1 can lead to a variety of diseases, such as cancer, inflammation, and neurodegenerative disorders ^[154][155].

Polyphenols can inhibit AP-1 activity by (i) blocking the binding of AP-1 to DNA, (ii) inactivating the AP-1 proteins, and (iii) interfering with the signal transduction pathways that activate AP-1 ^[155][156]. The inhibition of AP-1 activity has a number of beneficial effects, including reduced cell proliferation, increased cell differentiation, increased apoptosis, reduced inflammation, and increased antioxidant activity ^[156][157].

These findings suggest that polyphenols may have potential therapeutic applications for the prevention and treatment of a variety of diseases, including cancer ^[157][158], cardiovascular disease ^[158][159], and neurodegenerative diseases ^[159][160]. Some of the specific polyphenols that have been shown to inhibit AP-1 activity include EGCG, resveratrol, quercetin, luteolin, kaempferol, etc.

NOX, located in the cell membrane, are the main source of ^•O₂⁻ in non-phagocytic cells ^[160][161], and catalyze the transfer of an electron from the NADPH complex to FAD, leading to the first step in the reduction of O₂ to superoxide anion ^[161][162]. The only function of NOX1-5 and DUOX1-2 is to produce ^•O₂⁻, while other sources produce ROS as a byproduct (mitochondrial ETC, uncoupled NO synthase, or biochemical damage) ^[161][162]. In the particular case of NOX2, it has been associated with breast, colorectal, gastric, and prostate cancer, as well as myelomonocytic leukemia, among others. Extracellular ROS contribute to cancer, facilitating spread by creating an oncogenic environment that favors the formation of new micro-tumors and acts as a starting point for cell metastasis ^[162][163].

To remove extracellular ^•O₂⁻, antioxidant enzymes include the superoxide dismutase SOD3 (Cu/Zn-SOD), which catalyzes its dismutation into H₂O₂ ^[163][164]. Subsequently, catalase reduces H₂O₂ to H₂O. In cancer patients, there is a relationship between low SOD3 expression and NOX overproduction, favoring cancer progression ^[164][165]. Conversely, the reduction of extracellular ROS inhibits tumor growth and metastasis ^[165][166].

Several studies have investigated the potential of polyphenols to inhibit NOX activity and reduce ROS production and it has been observed that these natural compounds prevent NOX expression [14]. Several compounds that have been studied are resveratrol ^[166][167], quercetin ^[167][168], EGCG ^[168][169], and curcumin ^[169][170].

The critical PI3K/Akt axis is involved in various cellular pathway processes, including cell growth, proliferation, survival, and metabolism. Its deregulation is implicated in many diseases, including cancer, diabetes, and cardiovascular diseases ^[170][171]. Akt is a key regulator of cell survival and apoptosis (programmed cell death) ^[171][172].

Inhibition of PI3K limits downstream Akt activation. Several polyphenols, such as quercetin, resveratrol, and curcumin have been tested for inhibiting PI3K by phosphorylating phosphatidylinositol lipids ^[172][173]. These compounds have been examined in Akt inhibition, and their interference with Akt activation, by inhibiting its phosphorylation, has been observed.

The PI3K/Akt pathway also interacts with the mammalian target of the rapamycin pathway (mTOR), with a central role in cell growth and metabolism. Resveratrol and curcumin have been explored for their ability to inhibit mTOR signaling, even downstream of Akt ^[173][174].

The BCL-2 family of proteins (which includes both pro- and anti-apoptotic members) ^[174][175] regulates apoptosis and mediates the process by which mitochondria contribute to this pathway. The anti-apoptotic members (BCL-2 itself, BCL-XL, and MCL-1) prevent apoptosis by inhibiting the activation of pro-apoptotic proteins ^[175][176]. Disruption of the balance between pro- and anti-apoptotic members of the BCL-2 family is a common feature of many cancers, contributing to the survival and growth of cancer cells. Elevated levels of BCL-2 are related to cancer progression and resistance to chemotherapeutic treatments ^[176][177]. Certain polyphenols can modulate the BCL-2 activity, supporting apoptosis and inhibiting cancer cell growth ^[177][178]. Some polyphenols have been shown to down-regulate anti-apoptotic BCL-2 family members, tipping the balance in favor of pro-apoptotic proteins and sensitizing cancer cells to apoptosis ^[178][179]. This can lead to decreased cancer cell survival and enhanced response to anticancer therapies.